EP2721065
And-ANGPTL3-mótefni og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.6.2012EP published:
12.9.2018EP application number:
12727767.1
EP translation filed:
28.11.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
13.6.2032Expiry date:
13.6.2026Next due date:
30.6.2026
Title:
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
Timeline
Today
14.6.2012EP application
12.9.2018EP Publication
28.11.2018Translation submitted
15.1.2019Registration published
13.6.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, IncAddress:
777 Old Saw Mill River Road, 10591, Tarrytown, US
Inventor
Name:
Mark W. SleemanAddress:
Richmond, AU
Name:
Viktoria GusarovaAddress:
Pleasantville, US
Name:
Andrew J. MurphyAddress:
Croton-on-Hudson, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161498518 PDate:
17.6.2011Country:
US
Number:
201161578309 PDate:
21.12.2011Country:
US
Supplementary protection
SPC number:
SPC353
Classification
Categories:
C07K 16/22, A61K 39/395, A61P 3/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 21.5.2019
Expires: 13.6.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 9
Paid: 19.5.2020
Expires: 13.6.2021
Payer: Patice ehf.
Number: 10
Paid: 19.5.2021
Expires: 13.6.2022
Payer: Patice ehf.
Number: 11
Paid: 18.5.2022
Expires: 13.6.2023
Payer: Patice ehf.
Number: 12
Paid: 24.5.2023
Expires: 13.6.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 21.5.2024
Expires: 13.6.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.6.2025
Expires: 13.6.2026
Payer: Árnason Faktor ehf.